In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Brought to you by

Conceptus raises $28.7 in private placement

Executive Summary

Conceptus (contraceptive devices) netted $28.7mm from a private placement of 2.3mm common shares priced at $13.25 apiece, a 14% discount to the market average. Merrill Lynch led the financing, and was joined by Federated Kaufmann Fund (managed by Federated Investors), RS Investments, and seven additional investors.
Deal Industry
  • Medical Devices
  • Medical Devices
    • Implantable Devices
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies

UsernamePublicRestriction

Register